Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ANDE
|
Anne G Rex
VP, Strategy, Planning and Dev |
BUY
Grant, award, or other acquisition
|
Direct | 1,713 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Anne G Rex
VP, Strategy, Planning and Dev |
BUY
Grant, award, or other acquisition
|
Direct | 1,714 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian A Valentine
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian A Valentine
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,907 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian A Valentine
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,908 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian K. Walz
VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 1,656 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian K. Walz
VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 1,656 Added 50.0% |
-
|
Mar 02
2022 |
|
ANDE
|
Brian K. Walz
VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct | 1,656 Added 50.0% |
-
|
Mar 02
2022 |
|
PLYA
|
Maria M Miller |
BUY
Open market or private purchase
|
Direct | 5,250 Added 23.13% |
$49,770
$9.48 p/Share
|
Mar 02
2022 |
|
MCRI
|
Bob Farahi
President |
SELL
Payment of exercise price or tax liability
|
Direct | 44,821 Reduced 18.6% |
$3,658,738
$81.63 p/Share
|
Mar 02
2022 |
|
MCRI
|
Bob Farahi
President |
BUY
Exercise of conversion of derivative security
|
Direct | 82,001 Added 29.48% |
$1,705,621
$20.8 p/Share
|
Mar 02
2022 |
|
MNRL
|
Robert M. Roosa
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 6,250 Reduced 17.31% |
$156,250
$25.0 p/Share
|
Mar 02
2022 |
|
UCTT
|
David T Ibnale
Director |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 34.29% |
$1,142,000
$45.68 p/Share
|
Mar 02
2022 |
|
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 18,000 Reduced 0.76% |
$1,183,860
$65.77 p/Share
|
Mar 02
2022 |
|
GIC
|
Christopher Longhito
SVP & Chief Supply Chain Ofc. |
BUY
Other acquisition or disposition
|
Direct | 58 Added 7.51% |
$1,611
$27.78 p/Share
|
Mar 02
2022 |
|
GIC
|
Klaus Werner
SVP & Chief Marketing Officer |
BUY
Other acquisition or disposition
|
Direct | 214 Added 8.64% |
$5,945
$27.78 p/Share
|
Mar 02
2022 |
|
ROCK
|
William T Bosway
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,853 Reduced 1.52% |
$90,167
$48.66 p/Share
|
Mar 02
2022 |
|
ROCK
|
Patrick Burns
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 272 Reduced 0.8% |
$13,236
$48.66 p/Share
|
Mar 02
2022 |
|
ROCK
|
Timothy F. Murphy
Senior VP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 473 Reduced 0.65% |
$23,016
$48.66 p/Share
|
Mar 02
2022 |
|
ROCK
|
Jeffrey J. Watorek
VP and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 49 Reduced 0.46% |
$2,384
$48.66 p/Share
|
Mar 02
2022 |
|
ESTA
|
Jw Asset Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.16% |
$297,250
$59.45 p/Share
|
Mar 02
2022 |
|
ADUS
|
R Dirk Allison
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 1,432 Reduced 1.69% |
$120,603
$84.22 p/Share
|
Mar 02
2022 |
|
ADUS
|
Darby Anderson
EVP/Chief Legislative Officer |
SELL
Open market or private sale
|
Direct | 339 Reduced 0.94% |
$28,547
$84.21 p/Share
|
Mar 02
2022 |
|
ADUS
|
W Bradley Bickham
President and COO |
SELL
Open market or private sale
|
Direct | 277 Reduced 0.56% |
$23,332
$84.23 p/Share
|
Mar 02
2022 |
|
ADUS
|
Brian Poff
EVP/Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 448 Reduced 1.28% |
$37,731
$84.22 p/Share
|
Mar 02
2022 |
|
ADUS
|
Monica Raines
EVP/CCO and Quality Officer |
SELL
Open market or private sale
|
Direct | 76 Reduced 1.02% |
$6,401
$84.23 p/Share
|
Mar 02
2022 |
|
ADUS
|
David W. Tucker
EVP / Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 144 Reduced 1.32% |
$12,129
$84.23 p/Share
|
Mar 02
2022 |
|
ADUS
|
Michael D. Wattenbarger
EVP/Chief Information Officer |
SELL
Open market or private sale
|
Direct | 75 Reduced 0.86% |
$6,317
$84.23 p/Share
|
Mar 02
2022 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 34,820 Added 24.89% |
-
|
Mar 02
2022 |
|
SILK
|
Lucas W. Buchanan
COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 65,280 Added 20.69% |
-
|
Mar 02
2022 |
|
SILK
|
Richard Ruedy
EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct | 17,950 Added 11.71% |
-
|
Mar 02
2022 |
|
GDOT
|
Glinda Bridgforth Hodges
Director |
SELL
Open market or private sale
|
Direct | 3,910 Reduced 15.53% |
$106,548
$27.25 p/Share
|
Mar 02
2022 |
|
GDOT
|
Glinda Bridgforth Hodges
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 3,910 Added 13.44% |
$84,651
$21.65 p/Share
|
Mar 02
2022 |
|
USNA
|
Joshua Foukas
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 3,303 Reduced 100.0% |
$297,039
$89.93 p/Share
|
Mar 02
2022 |
|
AUPH
|
Robert Bindert Huizinga
EVP of Research |
SELL
Open market or private sale
|
Direct | 4,849 Reduced 6.53% |
$58,236
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Robert Bindert Huizinga
EVP of Research |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 10.27% |
-
|
Mar 02
2022 |
|
AUPH
|
Neil Solomons
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,846 Reduced 5.06% |
$58,200
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Neil Solomons
Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 8.15% |
-
|
Mar 02
2022 |
|
AUPH
|
Stephen P. Robertson
EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 42.12% |
-
|
Mar 02
2022 |
|
AUPH
|
Peter Greenleaf
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,068 Reduced 21.57% |
$108,907
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Peter Greenleaf
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 28,300 Added 40.24% |
-
|
Mar 02
2022 |
|
AUPH
|
Massimilano Colao
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 3,205 Reduced 19.19% |
$38,492
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Massimilano Colao
Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 33.73% |
-
|
Mar 02
2022 |
|
AUPH
|
Joseph M Miller
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,060 Reduced 31.64% |
$36,751
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Joseph M Miller
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 46.78% |
-
|
Mar 02
2022 |
|
AUPH
|
Matthew Maxwell Donley
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,052 Reduced 15.83% |
$36,655
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Matthew Maxwell Donley
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 30.6% |
-
|
Mar 02
2022 |
|
AUPH
|
Michael Robert Martin
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 4,849 Reduced 7.53% |
$58,236
$12.01 p/Share
|
Mar 02
2022 |
|
AUPH
|
Michael Robert Martin
Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,500 Added 11.67% |
-
|
Mar 02
2022 |
|
LOB
|
Steve Smits
Chief Credit Officer |
SELL
Open market or private sale
|
Indirect | 2,747 Reduced 1.62% |
$173,418
$63.13 p/Share
|
Mar 02
2022 |